The director of the Alleghany Health Network Institute of Cellular Therapeutics discussed possible applications of the procedure.
The chief scientific officer of the CMT Research Foundation discussed investigative cell and gene therapy approaches for treating CMT.
Oncologist discuss the possibility of earlier-line CAR T-cell therapies in MM.